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Abstract
Background: Propofol and fentanyl are the most widely administered anesthesia maintaining drugs during
colonoscopy. In this study, we determined the median effective concentration (EC50) of propofol required for
colonoscopy in elderly patients, and the purpose of this study was to describe the pharmacodynamic interaction
between fentanyl and propofol when used in combination for colonoscopy in elderly patients.
Methods: Ninety elderly patients scheduled for colonoscopy were allocated into three groups in a randomized,
double-blinded manner as below, F0.5 group (0.5 μg.kg−1 fentanyl), F1.0 group (1.0 μg.kg−1 fentanyl) and saline
control group. Anaesthesia was achieved by target-controlled infusion of propofol (Marsh model, with an initial
plasma concentration of 2.0 μg.ml−1) and fentanyl. Colonoscopy was started 3 min after the injection of fentanyl.
The EC50 of propofol for colonoscopy with different doses of fentanyl was measured by using an up-and-down
sequential method with an adjacent concentration gradient at 0.5 μg.ml−1 to inhibit purposeful movements.
Anaesthesia associated adverse events and recovery characters were also recorded.
Results: The EC50 of propofol for colonoscopy in elderly patients were 2.75 μg.ml−1 (95 % CI, 2.50–3.02 μg.ml−1) in
F0.5 group, 2.05 μg.ml−1 (95 % CI, 1.98–2.13 μg.ml−1) in F1.0 group and 3.08 μg.ml−1 (95 % CI, 2.78–3.42 μg.ml−1) in
control group respectively (P < 0.05). Patients in the F1.0 group had a significantly longer awake time and length of
hospital stay than those in control group (P < 0.05).
Conclusion: Increasing doses of fentanyl up to 1.0 μg.kg−1 reduces the propofol EC50 required for elderly patients
undergoing colonoscopy, and there was no significant difference in anaesthesia associated adverse events but
prolonged awake and discharge time.
Trial registration: Chinese Clinical Trial Registry ChiCTR15006368. Date of registration: May 3, 2015.
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Background
Colonoscopy is an essential screening and therapeutic
tool for colorectal diseases. It is usually performed under
sedation for higher patient acceptance and comfort [1, 2].
Propofol is a sedative-hypnotic drug and characterized by
a rapid onset and shorter recovery time with less postop-
erative nausea and vomiting [3, 4]. As a result, propofol is
appropriate for diagnostic and therapeutic procedures
such as outpatient anaesthesia procedures, including di-
gestive endoscopy [5], especially with a target controlled
infusion pattern [6]. Adjuvants are usually needed in many
cases because such co-administration can improve anaes-
thetic efficacy as well as patients’ satisfaction [7]. Fentanyl
is a short-acting potent opioid and is the most used opiate
during colonoscopy [2]. Whereas, the co-administration
of such drugs could induce supress of airway reflex, thus
increasing the risk of desaturation during colonoscopic
procedures. Elderly patients are the most sensitive popula-
tion to hypoxemia. Because they are usually complicated
with cardiopulmonary diseases and impaired renal or hep-
atic function [8]. Since colonoscopy is usually carried out
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in ambulatory settings, such contradiction could prolong
the recovery time and complicate the management [9, 10].
So, it is crucial to determine the pharmacodynamic inter-
action of propofol and fentanyl during sedation proce-
dures in elderly patients. We therefore designed this
randomized, double-blinded and controlled study to char-
acterizing the effect of different doses of fentanyl on the
median effective concentration (EC50) of propofol for
elective colonoscopy in elderly patients, which we hope
could provide new insights to a better management for
such clinical situations.
Methods
Study design and patient population
This randomized, double-blinded and controlled study
was approved by the Ethics Committee of Shanghai
Renji hospital and was also registered in Chinese Clinical
Trial Registry ChiCTR15006368. Elderly patients from the
outpatient department for colonoscopy from November,
2013 to July, 2014 were enrolled in the study and patients’
consents were signed before the surgical procedure.
Criteria for inclusion and exclusion
Patients were included if they (1) were 75–89 years old;
(2) were with American Society Anesthesiologists phys-
ical status (ASA) I–III; (3) had body mass index (BMI)
19–27 k.m−2.
Patients were excluded when they had (1) allergy to ei-
ther propofol or fentanyl; (2) chronic use of analgesics;
(3) alcohol abuse; (4) neurological or pyschiatric disor-
ders; (5) end stage liver or renal diseases or (6) sleep
Apnea Hypopnea Syndrome (SAHS).
Preoperative preparations and anesthesia protocol
During the preoperative evaluation, informed consent
was signed by the patient and his/her family member.
Patients were divided into one of this three groups by a
random number generated by computer, F0.5 group
(0.5 μg.kg−1fentanyl, n = 30), F1.0 group (1.0 μg.kg−1 fen-
tanyl, n = 30) and saline control group (equivalent volume
of normal saline, n = 30).
Upon arrival of the patient in the operating room, an
antecubital venous access was established and then
Ringer Lactate solution was administered. A nasal oxy-
gen catheter was started with a flow of 3 L.min−1. Heart
rate (HR), blood pressure (BP), electrocardiogram (ECG)
and pulse oximetry (SpO2) were monitored continuously
during the study.
After preoxygenation, computer-controlled TCI (Graseby™
3500 TCI Syringe Pump, London UK) was started, propofol
(AstraZeneca Company, Italy) was administered with a
Marsh pharmacokinetic parameters with an initial plasma
target concentration at 2.0 μg.ml−1 in this three groups.
We started the first dose of propofol at 2.0 μg.ml−1since
previous study determined that the Cp50 of propofol to
make elderly patients population to lose consciousness
was within this range. Once the target concentration
achieved, fentanyl was injected immediately. All fentanyl
solutions were diluted into 5 ml and was prepared by a
nurse who was no longer involved in the follow-up.
Patients were injected with different doses of fentanyl:
0.5 μg.kg−1 fentanyl (F0.5 group), 1.0 μg.kg−1 fentanyl
(F1.0 group) and blank saline solution (Control group).
Qualified endoscopists started colonoscopy procedure
3 min after fentanyl injection and TCI pump was sus-
pended just before the end of the procedure. Purposeful
movements, including head or limbs purposeful move-
ments during colonoscopy was defined as “responsive”.
If the patient presented “responsive”, the target plasma
concentration of propofol for the next patient would be
augmented with an adjacent concentration gradient at
0.5 μg.ml−1. If there was no purposeful movements oc-
curred, which defined as “non-responsive”, a lower-level
concentration which was decreased with an adjacent
gradient at 0.5 μg.ml−1would be adopted for the next
case. This method was called up-and-down method of
Dixon, described as early in 1965 [11].
Hypotension, which was define as a BP decrease of
30 % over the baseline value, was treated by fluid ther-
apy with accelerated infusion of Ringer Lactate and
bolus of 6–10 mg ephedrine. Bradycardia (HR < 50 bpm)
was treated with bolus of 0.5 mg atropine. Respiratory
depression (SpO2 less than 90 %) refractory to continu-
ous oxygen (3 L.min−1) inhalation was corrected by un-
armed airway opening. If pulse oximetry not improved
or spontaneous respiration always absent, an artificial
ventilation support would be provided.
Measurements
Baseline BP and HR were defined as the mean of the
two lowest measurements recorded during 3 min interval
just before the start of anesthesia. Values from all routine
anaesthetic monitors were recorded at a 3-min interval
duration of surgical procedure, while perioperative anaes-
thesia related adverse events, such as hypotension, brady-
cardia and frequency of respiratory depression also
recorded. The pump infusion of propofol was stopped at
the end of colonoscopy, which was defined as the removal
of the colonoscope. The time from discontinuing propofol
to obeying commands of eye opening was defined as
awake time. During postoperative PACU stay, the occur-
rence of postoperative nausea and vomiting (PONV) were
recorded and treated with antiemetics. The criteria for dis-
charging patients from the endoscopy unit were listed as
following: ability to respond appropriately to questions,
sitting upright for at least 5 min, and dressing without
assistance. The time from eye opening to discharge was
recorded as hospital discharge time.
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Statistical analysis
Studies have showed that anaesthesia studies using the
up-and down method typically need 20–40 patients per
group [4, 12]. We have also anticipated a lost follow-up
incidence of about 10 %. Therefore, the sample size was
set at 30 patients for each group. The EC50 of propofol
in each group was determined by a modification of
Dixon’s up-and-down method [4] and defined as the
mean cross-over midpoint in each group. Statistical ana-
lysis were performed by ANOVA and the comparisons
among EC50 groups depend on Mann-Whitney U test.
Values are expressed as mean and standard deviation or
number of patients. A P value less than0.05 was considered
to be statistically significant.
Results
All 90 patients completed the study without incorrigible
adverse effects such as severe hypoxemia, bradycardia or
hypotension. Patients’ demographic data and character-
istics are presented in Table 1, and they were similar in
terms of age, weight, BMI, ASA physical status, coex-
isted diseases and colonoscopy duration (P > 0.05).
The target concentration of propofol in plasma for
consecutive patients and their responses to the colonos-
copy procedure are shown in Fig. 1. Propofol EC50 and
its 95 % confidence interval were 2.75 (2.50–3.02) μg.ml−1
in F0.5 group, 2.05 (1.98–2.13) μg.ml−1in F1.0group and
3.08 (2.78–3.42) μg.ml−1 in Control group respectively
(shown in Table 2). When EC50 of propofol compared
among groups, there was no statistically significant
difference between F0.5 group and Control group
(P > 0.05), whereas, EC50 of propofol in F1.0 group
was statistically significantly decreased compared to
Control group (P < 0.05).
The incidence of adverse events during colonoscopy
were listed in Table 2. There were no significant differ-
ence in total anaesthesia related adverse events among
three groups, while the incidence of PONV was signifi-
cantly increased in F1.0 group. Patients in F1.0 group
but not F0.5group had statistically significantly longer
awake time and length of hospital stay (P < 0.05,
Table 2).
Discussion
The primary objective of this study was to evaluate the
impact of the combination of fentanyl on the needs of
propofol to achieve a targeted sedative depth for colonos-
copy in elderly patients. Our results show a significant re-
duction in propofol requirement when co-administration
with 1 μg.kg−1of fentanyl rather than 0.5 μg.kg−1. This
finding was meaningful because it confirmed that
anaesthetics had interactions and an optimal combin-
ation method should be investigated to ensure both
safety and effectiveness, especially for elderly patients.
Because many studies demonstrated that the propofol
requirements are reduced in elderly individuals [13, 14].
This can be explained by age-related changes in pharma-
cokinetics, pharmacodynamics or both [15]. Other study
confirmed that age increases the sensitivity of the brain to
propofol [14].
Our study has adopted a plasma TCI infusion mode
for propofol. Studies have confirmed that the onset and
recovery time of propofol by plasma TCI mode were sig-
nificantly shorter than traditional infusion mode [9, 10].
Fentanyl is frequently used with propofol for sedative
surgical procedures and the usual doses are usually set
at 50–200 micrograms [1]. We administrated patients
with fentanyl at 0.5 μg.kg−1 or 1.0 μg.kg−1, which is per-
fectly located in the safe dosage spectrum.
Sequential design methods are usually employed for
the determination of the concentration or dose associ-
ated with the 50 % point along the dose-response curve,
so EC50 or ED50 is commonly used as a measure of
drug’s potency [16, 17]. The up-and down method of
Dixon has a very long history [18, 19] and is commonly
used in anesthesia research [4]. Now, developments in
statistical methods have allowed study designs for the
measurements of the response at any point along the
dose-response curve. Since propofol and fentanyl have
“synergic effects”, their interactions should be further in-
vestigated to make sure a both safe and potent anaesthe-
sia for all patients.
Several limitations in the present study should be
mentioned. Firstly, we defined purposeful head or limbs
movement during surgical procedure as “responsive”,
however, it is subjective and further studies combined
with quantified methods, such as BIS or entropy moni-
toring are highly needed [20]. Secondly, we applied
Marsh TCI model for propofol infusion. Studies showed
that Marsh model does not make any adjustments for
age [21], since it assumes identical concentrations of the
Table 1 Demographic data and patients’ characters (n = 30 in
each group)
Control Group F0.5 Group F1.0
Gender (M/F) 17/13 14/16 15/15
Age (yrs) 78.2 ± 9.2 79.6 ± 6.1 82.1 ± 7.9
BMI (kg/m2) 23.3 ± 2.2 25.2 ± 1.5 24.5 ± 2.5
ASA (II/III) 24/6 25/5 27/3
Hypertension 26/4 24/6 26/4
Diabetes 17/13 18/12 15/15
Drug allergies 3/27 3/27 4/26
Smoking history 11/19 12/18 11/19
Snoring 10/20 9/21 8/22
Colonoscopy time (min) 15.2 ± 1.8 14.6 ± 2.2 16.2 ± 1.9
Values are expressed as mean ± SD or number of patients
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drugs, regardless of the age. So, the concentration in our
study might actually be higher than expected and lead to
hemodynamic instability [20, 21]. Other models, taking
age factor into account, such as Schnider model [21]
should be considered in our next step. Finally, due to
the long duration of the study, large number of anaes-
thesiologists and nurses were involved, and thus, the
results were slightly inclined to bias.
Fig. 1 Consecutive target propofol concentrations during colonoscopy insertion for EC50 determination. The lines represent the mean propofol
concentration when crossing from a failure to suppress patient movements. The average of these concentrations is defined as EC50. Propofol
EC50 was 3.08 with 95 % CI of 2.78–3.42 μg.ml−1 in control group (shown in Fig. 1a); while EC50 in F0.5 group was 2.75 with 95 % CI of 2.50–3.02 μg.ml−1
(shown in Fig. 1b) and 2.05 with 95 % CI of 1.98–2.13 μg.ml−1 in F1.0 group (shown in Fig. 1c)
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Conclusions
In conclusion, this randomized, double-blinded and con-
trolled trial for elderly patients undergoing ambulatory
colonoscopy showed that EC50 of propofol detected by
Dixon’s up-and-down method in such procedure was
decreased when combined with 1 μg.kg−1 fentanyl. No
severe adverse events were observed in present study
except prolonged recovery time after anaesthesia.
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Table 2 Propofol EC50, anesthesia related adverse events and
recovery time (n = 30 in each)
Control Group F0.5 group F1.0
Propofol EC50 (μg.ml−1) 3.08 2.75 2.05*
95 % CI (μg.ml−1) 2.78–3.42 2.50–3.02 1.98–2.13
Adverse events
Hypotension 2 1 1
Bradycardia 2 3 1
Respiratory depression 1 1 2
PONV 2 3 6 *
Total 7 (23.3 %) 8 (26.7 %) 10 (33.3 %)
Awake time (min) 6.2 ± 2.4 7.8 ± 3.1 9.6 ± 3.8*
Hospital discharge (min) 35.7 ± 5.9 38.2 ± 7.5 47.6 ± 10.2*
Values are expressed as mean ± SD or number of patients
*P < 0.05
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